STAGE IV RENAL CELL CANCER AJCC V7
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can breathing in a immune booster fight lung tumors?
Disease control OngoingThis study tests an inhaled form of interleukin-2 (IL-2), a protein that helps the immune system fight cancer. It is for people whose cancer has spread to the lungs from melanoma, sarcoma, or kidney cancer. The goal is to find the best dose and see if it can shrink lung tumors wi…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 12:08 UTC
-
Could a malaria drug help fight cancer? early trial tests new combo
Disease control OngoingThis early-phase trial tests two drugs together—MK-2206 and hydroxychloroquine—in people with advanced solid tumors, melanoma, kidney, or prostate cancer. The goal is to find the safest dose and see how the combination affects cancer cell growth. About 62 participants will take b…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 12:01 UTC
-
New drug combo aims to shrink metastatic kidney tumors
Disease control OngoingThis study tests whether adding entinostat to high-dose aldesleukin (interleukin-2) can help shrink tumors in people with metastatic kidney cancer. About 47 adults with clear cell renal cell carcinoma that has spread will receive both drugs. The goal is to find the safest dose an…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Can a pill stop kidney Cancer's return after surgery? new study investigates
Disease control OngoingThis study tests whether the drug pazopanib can delay or prevent kidney cancer from returning in patients who have had all visible tumors surgically removed. About 129 adults with advanced kidney cancer that spread to other parts of the body but showed no signs of disease after s…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
New combo therapy aims to shrink kidney tumors before surgery
Disease control OngoingThis early-phase study tests whether giving immunotherapy drugs (nivolumab alone or with bevacizumab or ipilimumab) before surgery is safe for people with advanced kidney cancer that has spread. About 104 participants will receive one of these treatments before their tumor is rem…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 17, 2026 12:03 UTC
-
Rare cancer hope: immune drug shows promise in phase 2 trial
Disease control OngoingThis study tested a drug called pembrolizumab in 157 people with rare cancers that had spread or couldn't be removed. The drug works by helping the body's immune system attack the cancer. The main goal was to see how many patients were alive and their cancer hadn't grown after 27…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:13 UTC